Transpact Enterprises Ltd

Transpact Enter. will announce its results on 14 November 2025.

As of October 23, 2025, Transpact Enter. is considered very expensive and overvalued, with a PE ratio of 913.07 and a price to book value of 9.13, significantly higher than its peers, indicating that investors should be cautious despite its recent strong performance against the Sensex.

As of October 7, 2025, Transpact Enter. is considered very expensive and overvalued, with a PE ratio of 9.13, an EV to EBITDA ratio of 9.12, and a low ROE of 1.00%, despite a strong recent stock performance of 27.93% compared to the Sensex's 1.08%.

Transpact Enter has shown fluctuating net sales and profitability, with a notable improvement in the most recent fiscal year, achieving net sales of 0.08 Cr in March 2025 and a profit after tax of 0.01 Cr, recovering from previous losses. However, total assets decreased to 0.66 Cr in March 2024, indicating reduced financial resources.

Transpact Enter. will announce its results on 04 September 2025.

As of 24th July, Transpact Enterprises Ltd has a market capitalization of 10.00 Cr, classifying it as a Micro Cap company. Recent financial data, including Net Sales and Net Profit, is unavailable, with Shareholder's Funds at 0.44 Cr and Total Assets at 0.66 Cr as of March 2024.

Transpact Enterprises Ltd is a micro-cap company in the capital markets sector, incorporated in 2013 and converted to a public company in 2019. It has a market cap of INR 11 Cr, with no recent revenue or profit data available.

The top shareholders of Transpact Enter are Raman Talwar with 16.03%, Kanchan Rani at 12.15%, and individual investors holding a combined 61.33%. There are no institutional or pledged promoter holdings reported.

As of March 2021, the management team of Transpact Enter includes Aslam Khan (Managing Director), Anis Choudhery (Whole-time Director), and independent directors Soummya Baig, Shariq Nisar, and Moiz Miyajiwala, along with Viraj Mane as Company Secretary. Each member contributes to the company's governance and operations.

As of June 5, 2025, Transpact Enter's trend is neutral, with a current price of 239.00 and insufficient technical indicators to assess its strength.

As of June 5, 2025, Transpact Enter's trend is neutral, with a current price of 239.00 and insufficient technical indicators to assess its strength.

As of June 3, 2025, Transpact Enter. is considered very expensive and overvalued with a PE ratio of 8.89 and an EV to EBITDA of 8.49, especially when compared to peers like Poly Medicure Ltd. and Blue Jet Health, despite a year-to-date stock return of 15.13%.

Transpact Enter.'s peers include HDFC AMC, Motil.Oswal.Fin., Nippon Life Ind., 360 ONE, CRISIL, Multi Comm. Exc., ICICI Securities, Angel One, and BSE. Multi Comm. Exc. leads in 1-year returns at 85.56%, while Transpact Enter. has the lowest at -29.42%.

As of 05-Jun, Transpact Enterprises Ltd is priced at 230.00 with no change in price. The stock has outperformed its sector today and shows a year-to-date gain of 10.79%, despite a significant decline of 29.42% over the past year.